The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
|
---|---|
Published in |
Frontiers in Bioengineering and Biotechnology, October 2022
|
DOI | 10.3389/fbioe.2022.1027868 |
Pubmed ID | |
Authors |
Rui Wang, Changming Zhao, Shuxia Jiang, Zhaohua Zhang, Chunmei Ban, Guiping Zheng, Yan Hou, Bingjin Jin, Yannan Shi, Xin Wu, Qiangqiang Zhao |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 1 | 11% |
Librarian | 1 | 11% |
Other | 1 | 11% |
Student > Doctoral Student | 1 | 11% |
Student > Bachelor | 1 | 11% |
Other | 3 | 33% |
Unknown | 1 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Engineering | 2 | 22% |
Unspecified | 1 | 11% |
Business, Management and Accounting | 1 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 11% |
Medicine and Dentistry | 1 | 11% |
Other | 1 | 11% |
Unknown | 2 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2022.
All research outputs
#18,601,965
of 23,041,514 outputs
Outputs from Frontiers in Bioengineering and Biotechnology
#3,445
of 6,735 outputs
Outputs of similar age
#303,456
of 439,369 outputs
Outputs of similar age from Frontiers in Bioengineering and Biotechnology
#254
of 699 outputs
Altmetric has tracked 23,041,514 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,735 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,369 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 699 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.